NEUROMARK Randomized Controlled Trial

NAActive, not recruitingINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

October 10, 2023

Primary Completion Date

March 31, 2025

Study Completion Date

March 31, 2025

Conditions
Chronic Rhinitis
Interventions
DEVICE

NEUROMARK System

The NEUROMARK System is indicated for use in otorhinolaryngology (ENT) surgery for creation of radiofrequency (RF) lesions to disrupt posterior nasal nerves in patients with chronic rhinitis.

DEVICE

Sham NEUROMARK System

Sham ablation procedure using the NEUROMARK System

Trial Locations (16)

18017

Bethlehem ENT, Bethlehem

21204

Centers for Advanced ENT Care, Baltimore

23235

Richmond ENT, Richmond

33426

ENT & Allergy Associates of Florida, Boynton Beach

34952

ENT & Allergy Associates of Florida, Port Saint Lucie

35204

ExcelENT, Homewood

36801

East Alabama ENT, Opelika

40205

Kentuckiana, Louisville

40220

Advanced ENT & Allergy, Louisville

46016

Ascension St. Vincent, Anderson

75708

The ENT & Allergy Centers of Texas, McKinney

77030

Houston Methodist ENT Specialists, Houston

90006

Sensa Health, Los Angeles

90503

Breathe Clear Institute, Torrance

95815

Sacramento ENT, Sacramento

98374-1145

ENT & Allergy Associates, Puyallup

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Neurent Medical

INDUSTRY

NCT06128200 - NEUROMARK Randomized Controlled Trial | Biotech Hunter | Biotech Hunter